Equities Analysts Issue Forecasts for Mesoblast Limited’s Q2 2018 Earnings (MESO)
Mesoblast Limited (NASDAQ:MESO) – Equities research analysts at Oppenheimer Holdings upped their Q2 2018 earnings per share (EPS) estimates for shares of Mesoblast Limited in a report released on Tuesday. Oppenheimer Holdings analyst M. Breidenbach now expects that the company will post earnings of ($0.19) per share for the quarter, up from their prior forecast of ($0.22). Oppenheimer Holdings currently has a “Buy” rating and a $16.00 target price on the stock. Oppenheimer Holdings also issued estimates for Mesoblast Limited’s Q3 2018 earnings at ($0.19) EPS, Q4 2018 earnings at ($0.19) EPS, FY2018 earnings at ($0.76) EPS, Q1 2019 earnings at ($0.19) EPS, Q2 2019 earnings at ($0.20) EPS, Q3 2019 earnings at ($0.21) EPS, Q4 2019 earnings at $0.06 EPS and FY2019 earnings at ($0.54) EPS.
Several other equities analysts have also issued reports on MESO. Zacks Investment Research lowered Mesoblast Limited from a “hold” rating to a “strong sell” rating in a report on Thursday. Maxim Group set a $14.00 price objective on Mesoblast Limited and gave the stock a “buy” rating in a report on Wednesday. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Mesoblast Limited in a report on Wednesday, August 23rd. ValuEngine lowered Mesoblast Limited from a “hold” rating to a “sell” rating in a report on Friday, September 15th. Finally, BidaskClub lowered Mesoblast Limited from a “sell” rating to a “strong sell” rating in a report on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $13.14.
TRADEMARK VIOLATION NOTICE: This news story was first published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was illegally stolen and republished in violation of U.S. & international copyright law. The legal version of this news story can be read at https://www.watchlistnews.com/equities-analysts-issue-forecasts-for-mesoblast-limiteds-q2-2018-earnings-meso/1713159.html.
Mesoblast Limited (NASDAQ MESO) opened at $5.03 on Friday. Mesoblast Limited has a twelve month low of $4.39 and a twelve month high of $12.50.
About Mesoblast Limited
Receive News & Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.